Literature DB >> 32738522

Aurora kinases and DNA damage response.

Hoi Tang Ma1, Randy Y C Poon2.   

Abstract

It is well established that Aurora kinases perform critical functions during mitosis. It has become increasingly clear that the Aurora kinases also perform a myriad of non-mitotic functions including DNA damage response. The available evidence indicates that inhibition Aurora kinase A (AURKA) may contribute to the G2 DNA damage checkpoint through AURKA's functions in PLK1 and CDC25B activation. Both AURKA and Aurora kinase B (AURKB) are also essential in mitotic DNA damage response that guard against DNA damage-induced chromosome segregation errors, including the control of abscission checkpoint and prevention of micronuclei formation. Dysregulation of Aurora kinases can trigger DNA damage in mitosis that is sensed in the subsequent G1 by a p53-dependent postmitotic checkpoint. Aurora kinases are themselves linked to the G1 DNA damage checkpoint through p53 and p73 pathways. Finally, several lines of evidence provide a connection between Aurora kinases and DNA repair and apoptotic pathways. Although more studies are required to provide a comprehensive picture of how cells respond to DNA damage, these findings indicate that both AURKA and AURKB are inextricably linked to pathways guarding against DNA damage. They also provide a rationale to support more detailed studies on the synergism between small-molecule inhibitors against Aurora kinases and DNA-damaging agents in cancer therapies.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer; Cancer therapies; DNA damage checkpoints; DNA repair; Mitosis

Year:  2020        PMID: 32738522     DOI: 10.1016/j.mrfmmm.2020.111716

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  10 in total

Review 1.  The Relevance of Aurora Kinase Inhibition in Hematological Malignancies.

Authors:  Caio Bezerra Machado; Emerson Lucena DA Silva; Beatriz Maria Dias Nogueira; Jean Breno Silveira DA Silva; Manoel Odorico DE Moraes Filho; Raquel Carvalho Montenegro; Maria Elisabete Amaral DE Moraes; Caroline Aquino Moreira-Nunes
Journal:  Cancer Diagn Progn       Date:  2021-07-03

2.  AURKA and PLK1 inhibition selectively and synergistically block cell cycle progression in diffuse midline glioma.

Authors:  Dennis S Metselaar; Aimée du Chatinier; Michaël H Meel; Giovanna Ter Huizen; Piotr Waranecki; Joshua R Goulding; Marianna Bugiani; Jan Koster; Gertjan J L Kaspers; Esther Hulleman
Journal:  iScience       Date:  2022-05-13

3.  Identification of the Hub Genes Associated with the Prognosis of Ovarian Cancer Patients via Integrated Bioinformatics Analysis and Experimental Validation.

Authors:  Yuzi Zhao; Jie Pi; Lihua Liu; Wenjie Yan; Shufang Ma; Li Hong
Journal:  Cancer Manag Res       Date:  2021-01-26       Impact factor: 3.989

4.  Potential role of glucosamine-phosphate N-acetyltransferase 1 in the development of lung adenocarcinoma.

Authors:  Shengqiang Zhang; Hongyan Zhang; Huawei Li; Jida Guo; Jun Wang; Linyou Zhang
Journal:  Aging (Albany NY)       Date:  2021-03-03       Impact factor: 5.682

Review 5.  Functional Coordination among the Golgi Complex, the Centrosome and the Microtubule Cytoskeleton during the Cell Cycle.

Authors:  Fabiola Mascanzoni; Roberta Iannitti; Antonino Colanzi
Journal:  Cells       Date:  2022-01-21       Impact factor: 6.600

Review 6.  Therapeutic Targeting of DNA Damage Response in Cancer.

Authors:  Wonyoung Choi; Eun Sook Lee
Journal:  Int J Mol Sci       Date:  2022-02-01       Impact factor: 5.923

7.  Structural Organization and Function of the Golgi Ribbon During Cell Division.

Authors:  Inmaculada Ayala; Antonino Colanzi
Journal:  Front Cell Dev Biol       Date:  2022-06-24

8.  Radiosensitivity in patients affected by ARPC1B deficiency: a new disease trait?

Authors:  Maria Chiriaco; Giorgiana Madalina Ursu; Donato Amodio; Nicola Cotugno; Stefano Volpi; Francesco Berardinelli; Simone Pizzi; Cristina Cifaldi; Matteo Zoccolillo; Ignazia Prigione; Silvia Di Cesare; Carmela Giancotta; Elisa Anastasio; Beatrice Rivalta; Lucia Pacillo; Paola Zangari; Alessandro G Fiocchi; Andrea Diociaiuti; Alessandro Bruselles; Francesca Pantaleoni; Andrea Ciolfi; Valentina D'Oria; Giuseppe Palumbo; Marco Gattorno; Maya El Hachem; Jean-Pierre de Villartay; Andrea Finocchi; Paolo Palma; Paolo Rossi; Marco Tartaglia; Alessandro Aiuti; Antonio Antoccia; Gigliola Di Matteo; Caterina Cancrini
Journal:  Front Immunol       Date:  2022-07-29       Impact factor: 8.786

9.  Identification and validation of pivotal genes related to age-related meniscus degeneration based on gene expression profiling analysis and in vivo and in vitro models detection.

Authors:  Ming Chen; Siqi Zhou; Huasong Shi; Hanwen Gu; Yinxian Wen; Liaobin Chen
Journal:  BMC Med Genomics       Date:  2021-09-29       Impact factor: 3.063

10.  Intra-heterogeneity in transcription and chemoresistant property of leukemia-initiating cells in murine Setd2-/- acute myeloid leukemia.

Authors:  Jiachun Song; Longting Du; Ping Liu; Fuhui Wang; Bo Zhang; Yinyin Xie; Jing Lu; Yi Jin; Yan Zhou; Gang Lv; Jianmin Zhang; Saijuan Chen; Zhu Chen; Xiaojian Sun; Yuanliang Zhang; Qiuhua Huang
Journal:  Cancer Commun (Lond)       Date:  2021-07-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.